Metropolitan Life Insurance Company (MetLife)’s La Jolla Pharmaceutical Company LJPC Stock Holding History

Metropolitan Life Insurance Company (MetLife)’s Portfolio LJPC Stock Details LJPC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-8,699	Closed	-$82K	–	2630
2018 Q4	$82K	Hold	8,699	–	–	﹤0.01%	2392
2018 Q3	$175K	Hold	8,699	–	–	﹤0.01%	2090
2018 Q2	$254K	Buy	8,699 +2,594	+42%	+$80.1K	﹤0.01%	1787
2018 Q1	$182K	Hold	6,105	–	–	﹤0.01%	1948
2017 Q4	$196K	Sell	6,105 -6,339	-51%	-$207K	﹤0.01%	1925
2017 Q3	$433K	Hold	12,444	–	–	﹤0.01%	1781
2017 Q2	$370K	Buy	12,444 +2,932	+31%	+$84K	﹤0.01%	1916
2017 Q1	$284K	Hold	9,512	–	–	﹤0.01%	2043
2016 Q4	$167K	Sell	9,512 -3,829	-29%	-$73.4K	﹤0.01%	2459
2016 Q3	$317K	Hold	13,341	–	–	﹤0.01%	2023
2016 Q2	$213K	Hold	13,341	–	–	﹤0.01%	2282
2016 Q1	$279K	Buy	13,341 +4,521	+51%	+$80.6K	﹤0.01%	1946
2015 Q4	$238K	Hold	8,820	–	–	﹤0.01%	2130
2015 Q3	$245K	Hold	8,820	–	–	﹤0.01%	2140
2015 Q2	$216K	Buy	+8,820	New	+$182K	﹤0.01%	2351

Other funds holding LJPC

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return

SAM

Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

VMI

VHCP Management III New York $504M AUM 683.12% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Metropolitan Life Insurance Company (MetLife)'s LJPC Position: Q1 2019 in Review

Metropolitan Life Insurance Company (MetLife) sold out of La Jolla Pharmaceutical Company (LJPC) in Q1 2019, closing a stake of 8,699 shares — an estimated $82K sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in LJPC in Q2 2015 and held it in 15 quarters. The position peaked at $433K in Q3 2017. 80 funds tracked by Wall St. Rank hold LJPC as of Q1 2019.

Metropolitan Life Insurance Company (MetLife) reported no remaining La Jolla Pharmaceutical Company position as of Q1 2019 after selling out during the quarter.
Metropolitan Life Insurance Company (MetLife) sold 8,699 La Jolla Pharmaceutical Company shares in Q1 2019, an estimated $82K.
Metropolitan Life Insurance Company (MetLife) first reported a position in La Jolla Pharmaceutical Company in Q2 2015 and held it in 15 quarters.
Metropolitan Life Insurance Company (MetLife)'s La Jolla Pharmaceutical Company position peaked at $433K in Q3 2017.
80 funds tracked by Wall St. Rank held La Jolla Pharmaceutical Company as of Q1 2019.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q1 2019, filed 15 May 2019.